BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17116441)

  • 1. Antimicrobial therapy of Clostridium difficile-associated diarrhea.
    Bouza E; Burillo A; Muñoz P
    Med Clin North Am; 2006 Nov; 90(6):1141-63. PubMed ID: 17116441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile-associated diarrhea: resurgence with a vengeance.
    Oldfield EC
    Rev Gastroenterol Disord; 2006; 6(2):79-96. PubMed ID: 16699477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.
    Lee YC; Wang JT; Chen AC; Sheng WH; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2012 Aug; 45(4):287-95. PubMed ID: 22209696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile-associated diarrhea and colitis.
    Gerding DN; Johnson S; Peterson LR; Mulligan ME; Silva J
    Infect Control Hosp Epidemiol; 1995 Aug; 16(8):459-77. PubMed ID: 7594392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative treatments for Clostridium difficile disease: what really works?
    McFarland LV
    J Med Microbiol; 2005 Feb; 54(Pt 2):101-111. PubMed ID: 15673502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-outbreak of Clostridium difficile associated diarrhea (CDAD) in a tertiary-care hospital.
    Souza Dias MB; Yamashiro J; Borrasca VL; Stempliuk VA; Araújo MR; Costa SF; Levin AS
    Rev Inst Med Trop Sao Paulo; 2010; 52(3):133-7. PubMed ID: 20602022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing spectrum of clostridium difficile associated disease: implications for dentistry.
    Blossom DB; Lewis FM; McDonald LC
    J Am Dent Assoc; 2008 Jan; 139(1):42-7. PubMed ID: 18167383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diarrhea associated with Clostridium difficile: one-year experience in a general hospital].
    Bouza E; Padilla B; Catalán P; Sánchez-Carrillo C; Blázquez R; Peláez T
    Rev Clin Esp; 1996 Jul; 196(7):424-30. PubMed ID: 8804202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Clostridium difficile-associated diarrhea.
    Malnick SD; Zimhony O
    Ann Pharmacother; 2002 Nov; 36(11):1767-75. PubMed ID: 12398575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile in long-term-care facilities for the elderly.
    Simor AE; Bradley SF; Strausbaugh LJ; Crossley K; Nicolle LE;
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):696-703. PubMed ID: 12452300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of Clostridium difficile colonization.
    Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.